Kristina S Boye
Dr Kristina S Boye, PhD, MSc is an expert in Endocrinology at Eli Lilly (United States) (United States). As of October 2026, ScienceLeadR ranks Kristina S Boye in the top 1% of experts worldwide for Diabetes Mellitus and Glucose Metabolism Disorders. Kristina S Boye has authored 233 publications, the most recent in 2026. SLR score: 670 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Public Health - Internal Medicine - Nutrition
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2007 - 2026
Number : 233
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Qualitative Exit Interviews to Characterize the Positive Treatment Experiences of Patients in the Phase III Trial of Orforglipron Versus Oral Semaglutide for the Treatment of Type 2 Diabetes. PMID 42888373 — diabetes mellitus, glucagon-like peptide 1, hemoglobins, outcome assessment, health care, weight loss, glucagon, therapeutics, glucagon-like peptides, glycemic control, diabetes mellitus, type 2, semaglutide | Patient | 2026 | 0 |
| Exit Interviews Examining Patient Experiences with Tirzepatide and Dulaglutide for Treatment of Type 2 Diabetes in the SURPASS-CVOT Trial. PMID 42754765 — diabetes mellitus, therapeutics, diabetes mellitus, type 2 | Diabetes Ther | 2026 | 0 |
| Costs of Comorbidities and Complications Associated with Type 2 Diabetes: A Retrospective, Cohort Study. PMID 42599581 — diabetes mellitus, comorbidity, cohort studies, drug therapy, diagnosis, diabetes mellitus, type 2 | Adv Ther | 2026 | 0 |
| Development of the Pediatric Type 2 Diabetes Impact Measure (P-TIM). PMID 42223861 — diabetes mellitus, caregivers, patient reported outcome measures, therapeutics, child, diabetes mellitus, type 2, weight control | J Patient Rep Outcomes | 2026 | 0 |
| Psychometric Validation of the Weight and Emotions Scale (WES) in Adults with Obesity or Overweight. PMID 42176180 — emotions, drug therapy, obesity, diagnosis, psychometrics, overweight | Adv Ther | 2026 | 0 |
LeadR Networks
Main global connection map